Literature DB >> 32649920

Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Hiroto Hatabu1, Gary M Hunninghake2, Luca Richeldi3, Kevin K Brown4, Athol U Wells5, Martine Remy-Jardin6, Johny Verschakelen7, Andrew G Nicholson8, Mary B Beasley9, David C Christiani10, Raúl San José Estépar11, Joon Beom Seo12, Takeshi Johkoh13, Nicola Sverzellati14, Christopher J Ryerson15, R Graham Barr16, Jin Mo Goo17, John H M Austin18, Charles A Powell19, Kyung Soo Lee20, Yoshikazu Inoue21, David A Lynch22.   

Abstract

The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4-9% of smokers and 2-7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32649920      PMCID: PMC7970441          DOI: 10.1016/S2213-2600(20)30168-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  97 in total

1.  Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis.

Authors:  Sang Min Lee; Joon Beom Seo; Sang Young Oh; Tae Hoon Kim; Jin Woo Song; Sang Min Lee; Namkug Kim
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

2.  Interstitial lung diseases in a lung cancer screening trial.

Authors:  N Sverzellati; L Guerci; G Randi; E Calabrò; C La Vecchia; A Marchianò; A Pesci; M Zompatori; U Pastorino
Journal:  Eur Respir J       Date:  2011-01-13       Impact factor: 16.671

3.  Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests.

Authors:  M Remy-Jardin; J Remy; C Boulenguez; A Sobaszek; J L Edme; D Furon
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

4.  Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage.

Authors:  M Remy-Jardin; J Remy; B Wallaert; D Bataille; P Y Hatron
Journal:  Radiology       Date:  1993-08       Impact factor: 11.105

5.  Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.

Authors:  Mary B Rice; Wenyuan Li; Joel Schwartz; Qian Di; Itai Kloog; Petros Koutrakis; Diane R Gold; Robert W Hallowell; Chunyi Zhang; George O'Connor; George R Washko; Gary M Hunninghake; Murray A Mittleman
Journal:  Thorax       Date:  2019-08-07       Impact factor: 9.139

6.  Telomere shortening in familial and sporadic pulmonary fibrosis.

Authors:  Jennifer T Cronkhite; Chao Xing; Ganesh Raghu; Kelly M Chin; Fernando Torres; Randall L Rosenblatt; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

7.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

8.  Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Hilary F Armstrong; Anna J Podolanczuk; R Graham Barr; Elizabeth C Oelsner; Steven M Kawut; Eric A Hoffman; Russell Tracy; Naftali Kaminski; Robyn L McClelland; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 30.528

9.  Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Authors:  I Puzanov; A Diab; K Abdallah; C O Bingham; C Brogdon; R Dadu; L Hamad; S Kim; M E Lacouture; N R LeBoeuf; D Lenihan; C Onofrei; V Shannon; R Sharma; A W Silk; D Skondra; M E Suarez-Almazor; Y Wang; K Wiley; H L Kaufman; M S Ernstoff
Journal:  J Immunother Cancer       Date:  2017-11-21       Impact factor: 13.751

10.  Classification of Interstitial Lung Abnormality Patterns with an Ensemble of Deep Convolutional Neural Networks.

Authors:  David Bermejo-Peláez; Samuel Y Ash; George R Washko; Raúl San José Estépar; María J Ledesma-Carbayo
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

View more
  55 in total

1.  Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial.

Authors:  Thomas Sonnweber; Piotr Tymoszuk; Sabina Sahanic; Anna Boehm; Alex Pizzini; Anna Luger; Christoph Schwabl; Manfred Nairz; Philipp Grubwieser; Katharina Kurz; Sabine Koppelstätter; Magdalena Aichner; Bernhard Puchner; Alexander Egger; Gregor Hoermann; Ewald Wöll; Günter Weiss; Gerlig Widmann; Ivan Tancevski; Judith Löffler-Ragg
Journal:  Elife       Date:  2022-02-08       Impact factor: 8.140

2.  CT-defined visual emphysema in smokers with normal spirometry: association with prolonged air leak and other respiratory complications after lobectomy for lung cancer.

Authors:  Taeyoung Yun; Hyewon Choi; Hyungjin Kim; Kwon Joong Na; Samina Park; In Kyu Park; Chang Hyun Kang; Jin Mo Goo; Young Tae Kim
Journal:  Eur Radiol       Date:  2022-01-29       Impact factor: 5.315

Review 3.  Association of pre-existing lung interstitial changes with immune-related pneumonitis in patients with non-small lung cancer receiving immunotherapy.

Authors:  Xiuqiong Chen; Zhaona Li; Xinyue Wang; Jing Zhou; Qianhui Wei; Richeng Jiang
Journal:  Support Care Cancer       Date:  2022-04-11       Impact factor: 3.603

4.  Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers.

Authors:  Aravind A Menon; Rachel K Putman; Jason L Sanders; Takuya Hino; Akinori Hata; Mizuki Nishino; Auyon J Ghosh; Samuel Y Ash; Ivan O Rosas; Michael H Cho; David A Lynch; George R Washko; Edwin K Silverman; Hiroto Hatabu; Gary M Hunninghake
Journal:  Chest       Date:  2021-11-03       Impact factor: 9.410

5.  Associations of sleep duration and sleep-wake rhythm with lung parenchymal abnormalities on computed tomography: The MESA study.

Authors:  John S Kim; Hassan S Dashti; Tianyi Huang; Brian E Cade; Anna J Podolanczuk; Daniel J O'Hearn; Eric A Hoffman; Heming Wang; John Blaikley; R Graham Barr; Susan Redline
Journal:  J Sleep Res       Date:  2021-09-09       Impact factor: 5.296

Review 6.  Update in Interstitial Lung Disease 2020.

Authors:  Anna J Podolanczuk; Alyson W Wong; Shigeki Saito; Joseph A Lasky; Christopher J Ryerson; Oliver Eickelberg
Journal:  Am J Respir Crit Care Med       Date:  2021-06-01       Impact factor: 21.405

7.  Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series.

Authors:  Ioana A Dobre; Angela J Frank; Kristin M D'Silva; David C Christiani; Daniel Okin; Amita Sharma; Sydney B Montesi
Journal:  Clin Lung Cancer       Date:  2021-02-04       Impact factor: 4.785

8.  Atypical presentation of nontuberculous mycobacterial pulmonary infection in a patient with interstitial lung abnormality: A case report.

Authors:  Jongmin Park; Byunggeon Park
Journal:  Eur J Radiol Open       Date:  2021-05-20

9.  Progress and Research Priorities in Imaging Genomics for Heart and Lung Disease: Summary of an NHLBI Workshop.

Authors:  Donna K Arnett; Ramachandran S Vasan; Matthew Nayor; Li Shen; Gary M Hunninghake; Peter Kochunov; R Graham Barr; David A Bluemke; Ulrich Broeckel; Peter Caravan; Susan Cheng; Paul S de Vries; Udo Hoffmann; Márton Kolossváry; Huiqing Li; James Luo; Elizabeth M McNally; George Thanassoulis
Journal:  Circ Cardiovasc Imaging       Date:  2021-08-13       Impact factor: 8.589

Review 10.  Interstitial Lung Abnormalities: State of the Art.

Authors:  Akinori Hata; Mark L Schiebler; David A Lynch; Hiroto Hatabu
Journal:  Radiology       Date:  2021-08-10       Impact factor: 29.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.